Boston Scientific seen pursuing divestitures

(Reuters) - They also forecast that Boston Scientific, which recently
hired a new chief financial officer, Sam Leno, is poised to
announce big job cuts in the second half of this year as sales
in its key stent business wane.




"I think accelerates the whole process. He is
focused on operating margins, which are very depressed right
now," said Jeff Jonas, a portfolio manager at Gamco Medical
Opportunities Fund.


Read more at Reuters.com Mergers News

US CREDIT-Boston Scientific spreads may offer some value

(Reuters) - A federal judge ruled on Tuesday that some
product-liability claims against Boston Scientific over
implantable heart defibrillators, which regulate abnormal
heartbeats, can proceed to trial, rejecting the company's
motions to dismiss them. For details, see [ID:nN13335046]




Guidant Corp., which Boston Scientific bought last year,
continued to sell heart rhythm-management devices after
learning of possible defects, a U.S. District Court judge in
Minnesota said in the ruling.


Read more at Reuters.com Bonds News